Home › IGA Glomerulonephritis › Massachusetts
IGA Glomerulonephritis clinical trials in Massachusetts
3 studies for IGA Glomerulonephritis are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- The Vasculitis and Glomerulonephritis Center at Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- UMass Memorial Medical Center, Worcester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06935357A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US
- Novartis Investigational site, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 17, 2025 · NCT06952426Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
- Clinical Research Site 369, Boston
RecruitingPhase 2
Ages 16 and older · All sexes · Updated Apr 6, 2025 · NCT06740526From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.